The failure to diagnose inborn errors of metabolism in New Zealand: The case for expanded newborn screening

New Zealand Medical Journal

Volumn 120, Issue 1262, 2007, Pages

  Wilson, Callum ^a   Kerruish, Nicola J ^b   Wilcken, Bridget ^c   Wiltshire, Ecko ^d   Webster, Dianne ^a  

^a AUCKLAND CITY HOSPITAL   (New Zealand)

^b UNIVERSITY OF OTAGO   (New Zealand)

^c CHILDREN S HOSPITAL AT WESTMEAD   (Australia)

^d WELLINGTON HOSPITAL   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; AUSTRALIA; CHILD; CYANOCOBALAMIN DEFICIENCY; DIAGNOSTIC ERROR; DIAGNOSTIC VALUE; DISORDERS OF AMINO ACID AND PROTEIN METABOLISM; EARLY DIAGNOSIS; ENZYME DEFICIENCY; HUMAN; INBORN ERROR OF METABOLISM; INCIDENCE; MAJOR CLINICAL STUDY; MAPLE SYRUP URINE DISEASE; MEDIUM CHAIN ACYL COENZYME A DEHYDROGENASE DEFICIENCY; NEW ZEALAND; NEWBORN; NEWBORN SCREENING; PRENATAL DIAGNOSIS; TANDEM MASS SPECTROMETRY; BLOOD; COMPARATIVE STUDY; EVALUATION; HEALTH CARE QUALITY; METHODOLOGY; UTILIZATION REVIEW;

HUMANS; INCIDENCE; INFANT, NEWBORN; METABOLISM, INBORN ERRORS; NEONATAL SCREENING; NEW SOUTH WALES; NEW ZEALAND; PROCESS ASSESSMENT (HEALTH CARE); TANDEM MASS SPECTROMETRY;

EID: 35549002151     PISSN: None     EISSN: 11758716     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Applegarth DA, Toone JR, Lowry RB. Incidence of inborn errors of metabolism in British Columbia, 1969-1996. Pediatrics. 2000;105:e10.
2. Sanderson S, Green A, Preece MA, Burton H. The incidence of inherited metabolic disorders in the West Midlands, UK. Arch Dis Child. 2006;91:896-9.
3. Tran K, Banerjee S, Li H, et al. Clinical efficacy and cost-effectiveness of newborn screening for medium chain acyl-CoA dehydrogenase deficiency using tandem mass spectrometry. Clin Biochem. 2007;40:235-41.
4. Schulze A, Lindner M, Kohlmuller D, et al. Expanded newborn screening for inborn errors of metabolism by electrospray ionization-tandem mass spectrometry: Results, outcome, and implications. Pediatrics. 2003;111:1399-406.
5. Wilcken B, Wiley V, Hammond J, Carpenter K Screening newborns for inborn errors of metabolism by tandem mass spectrometry. N Engl J Med. 2003;348:2304-12.
6. Wilcken B, Haas M, Joy P, et al. Outcome of neonatal screening for medium-chain acyl-CoA dehydrogenase deficiency in Australia: A cohort study. Lancet. 2007;369:37-42.
7. Births, Deaths and Marriages - Whanautanga, Matenga, Marenatanga. http://www.dia.govt.nz/diawebsite.NSF/wpg_URL/ Services-Births-Deaths-and-Marriages-Index?OpenDocument
8. The NSW Registry of Births Deaths & Marriages http://www.bdm.nsw.gov.au/births/births.htm
9. Iafolla AK, Thompson RJ Jr, Roe CR. Medium-chain acyl-coenzyme A dehydrogenase deficiency: Clinical course in 120 affected children. J Pediatr. 1994;124:409-15.
10. Wilson CJ, Champion MP, Collins JE, et al. Outcome of medium chain acyl-CoA dehydrogenase deficiency after diagnosis. Arch Dis Child. 1999;80:459-62.
11. Derks TG, Reijngoud DJ, Waterham HR, et al. The natural history of medium-chain acyl CoA dehydrogenase deficiency in the Netherlands: clinical presentation and outcome. J Pediatr. 2006;148:665-70.
12. Wilhelm GW. Sudden death in a young woman from medium chain acyl-coenzyme A dehydrogenase (MCAD) deficiency. J Emerg Med. 2006;30:291-4.
13. Mayell SJ, Edwards L, Reynolds FE, Chakrapani AB. Late presentation of medium-chain acyl-CoA dehydrogenase deficiency. J Inherit Metab Dis. 2007;30:104
14. Lee PJ, Harrison EL, Jones MG, Jones S, Leonard JV, Chalmers RA. L-carnitine and exercise tolerance in medium-chain acyl-coenzyme A dehydrogenase (MCAD) deficiency: A pilot study. J Inherit Metab Dis. 2005;28:141-52.Milne RJ, Slack A, Cumming J. Economic Evaluation of a Tandem Mass Spectrometer to Screen for Fatty Acid Oxidation Disorders in Neonates. Health Outcomes Associates Ltd & University of Auckland. August 2002.
15. Andresen BS, Dobrowolski SF, O'Reilly L, et al. Medium-chain acyl-CoA dehydrogenase (MCAD) mutations identified by MS/MS-based prospective screening of newborns differ from those observed in patients with clinical symptoms: Identification and characterization of a new, prevalent mutation that results in mild MCAD deficiency. Am J Hum Genet. 2001;68:1408-18
16. Waddell L, Wiley V, Carpenter K, et al. Medium-chain acyl-CoA dehydrogenase deficiency: Genotype-biochemical phenotype correlations. Mol Genet Metab. 2006;87:32-9
17. den Boer ME, Wanders RJ, Morris AA, et al. Long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency: Clinical presentation and follow-up of 50 patients. Pediatrics. 2002;109:99-104.
18. Dionisi-Vici C, Deodato F, Roschinger W, et al. 'Classical' organic acidurias, propionic aciduria, methylmalonic aciduria and isovaleric aciduria: Long-term outcome and effects of expanded newborn screening using tandem mass spectrometry. J Inherit Mtb Dis. 2006;29:383-9.
19. Wilson CJ, Myer M, Darlow BA, et al. Severe holocarboxylase synthetase deficiency with incomplete biotin responsiveness resulting in antenatal insult in samoan neonates J Pediatr. 2005;147:115-8.
20. Wilson CJ. National Metabolic Service. Unpublished data; 2007
21. Gurian EA, Kinnamon DD, Henry JJ, Waisbren SE. Expanded newborn screening for biochemical disorders: The effect of a false-positive result. Pediatrics. 2006;117:1915-21.
22. Hewlett J, Waisbren SE. A review of the psychosocial effects of false-positive results on parents and current communication practices in newborn screening. J Inherit Metab Dis. 2006;29:677-82
23. Starship Foundation website. http://www.starship.org.nz/index.php/ pi_pageid/15334
24. Bennett MJ, Ragni MC, Ostfeld RJ, et al Population screening for medium-chain acyl-CoA dehydrogenase deficiency: Analysis of medium-chain fatty acids and acylglycines in blood spots. Ann Clin Biochem. 1994;31:72-7.
25. Ziadeh R, Hoffman EP, Finegold DN, Hoop RC, Brackett JC, Strauss AW, Naylor EW. Medium chain acyl-CoA dehydrogenase deficiency in Pennsylvania: Neonatal screening shows high incidence and unexpected mutation frequencies. Pediatr Res. 1995;37:675-8.